Combined treatment with reaferon and iodantipirin in patients with chronic viral hepatitides B and C
Beloborodova, E.I.; Vnushinskaia, M.A.; Beloborodova, E.V.; Rachkovskiĭ, M.I.; Shalovaĭ, A.A.; Burkovskaia, V.A.; Saratikov, A.S.; Kuz'menko, D.I.
Terapevticheskii Arkhiv 77(2): 75-77
2005
ISSN/ISBN: 0040-3660 PMID: 15807459 Document Number: 593271
Aim. To examine clinical efficacy of combined therapy with reaferon and iodantipirin in patients with chronic hepatitis B and C of moderate activity.Material and methods. 100 patients with confirmed diagnosis of chronuic viral hepatitis (CVH) at the stage of replication. All the patients have undergone puncture biopsy of the liver with estimation of index of histological activity Knodell and index of fibrosis Desmeth.Results. Comparative evaluation was made of clinical efficacy of combined therapy reaferon+ iodantipirin and monotherapy with reaferon in 100 patients with moderate activity CHB and C.Conclusion. Conventional scheme with reaferon turned out less effective than the above combination therapy.